AFRICA Mauritania Mauritius Morocco Mozambique Namibia Niger Nigeria Republic-of-Congo Rwanda Sao-tome-and-Principe Senegal Seychelles Sierra-Leone Somalia South-Africa Sudan Swaziland Tanzania The-Gambia Togo Tunisia Uganda	ASIA -PACIFIC Australia Palau Brunei Papua-guinea Burma Samoa Cambodia Singapore China Solomon-islands East-timor South-korea Fiji Taiwan Indonesia Tajikistan Japan Thailand Kazakhstan The-Philippines Kiribati Tonga Kyrgyzstan Turkmenistan Laos Tuvalu Malaysia Uzbekistan Marshall-islands Vanuatu Micronesia Vietnam Mongolia     Nauru     New-zealand     North-korea	UNITED STATES Antigua & Barbuda Guyana Bahamas Grenada Barbados Haiti Belize Honduras Bolivia Jamaica Brazil Mexico Canada Nicaragua Chile St-lucia Costa-rica Suriname Cuba St-kitts-and-nevis Colombia Trinidad-and-tobago Dominica Uruguay Dominican-republic Venezuela Ecuador El-salvador Guatemala
Europe Albania Liechtenstein Andorra Lithuania Armenia Luxembourg Austria Macedonia Azerbaijan Malta Belarus Moldova Belgium Monaco Bosnia-hercegovina Montenegro Bulgaria Norway	Middle East Algeria Mauritania Egypt Oman Iran Qatar Iraq Saudi-arabia Israel-&-palestinian Sudan Jordan Syria Kuwait Tunisia Lebanon United-arab-emirates Libya Yemen	South Asia Afghanistan Bangladesh Bhutan India Nepal Pakistan Sri-Lanka The-Maldives
Croatia Poland Cyprus Portugal Czech-republic Russia Denmark San-marino Estonia Serbia Finland Slovakia France Slovenia Georgia Spain Germany Sweden Greece   Hungary   Iceland   Ireland   Italy   Latvia

Ensure Market Access for Innovative Medicines

In many countries market access to innovative medicines is often delayed or denied because of complex regulatory and reimbursement procedures. In practically all countries with price regulation, new medicines are not launched as long as reimbursement and pricing decisions are pending. There is a global trend that clinical guidelines and Health Technology Assessments (HTA) produced by health authorities or payers are often used as a mechanism to restrict access of patients to innovative medicines.

 

** Science for a better life - Medical Progress for the Benefit of the Patient

Home | Products | Quality | About Us |  | Drugs | Generic Medicine | Taj Generics | Generic Manufacturer | New Products |
Generic Market | New Brands  | New Generics  | Anti-Cancer Generics List | Generic Query | Manufacturing | Export & Import | contact | Pharmaceuticals Technology | Enquire Form | Contact Us | Legal Notice | Site Map | Privacy
Sitemap |  User Terms and Conditions |  Privacy and Cookie Statement

This site is copyright © 2004 - 2019 www.tajdrug.com - Taj Pharmaceuticals Ltd. - Taj Group of Companies
Generics Pharmaceuticals Manufacturing Company - India
Copyright © 2004-2019 Taj Pharmaceuticals Limited. All rights reserved.
The products discussed herein may have different product labeling in different countries. The product information
provided in this site is intended only for the residents of India. Best viewed of Firefox browser